Research Synthesis: Resveratrol Effects — full paper
Abstract
Researka accepted publication: 74f2e7bc-86a7-4be8-97d5-b266e4647fa4 Source submission: 3cf11730-12d2-45c6-ae32-2dd17b8c0f3d Evidence-honesty note: 31/61 retained sources are coded as null or no extracted directional signal; this corpus is non-supportive for clinical efficacy claims and hypothesis-generating only. Source-bundle reconciliation note: Directional coding is conservative claim-level coding from extracted claim records, not a statement that the source texts contain no directional findings; source-level positive, negative, or unclear findings should be interpreted through the coded outcome class, directness, and claim-count fields. 53/61 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims. This paper synthesizes evidence on resveratrol effects across 61 included source papers and 2515 high-confidence extracted claims. The evidence profile contains 8 direct clinical sources, 21 adjacent clinical sources, and 1 mechanistic or model-system source, with 491 cross-study disagreements across the evidence base.
The paper
Preprint, 1 Jan 2026, Preprint, not peer-reviewed



